Cryptococcus neoformans is a major pathogen in immunocompetant as well as immunocompromised patients including those with AIDS in both the developed as well as the developing world. Our long-term objective is to test the hypothesis that molecular regulators of the virulence factor laccase affect the virulence of Cryptococcus neoformans. The specific hypothesis behind the present proposal is that a virulence associated DEAD-box protein, Vad1, identified by insertional mutagenesis, is an important regulator of laccase and virulence in C. neoformans. In 2012, we completed our work demonstrating a role for Vad1-dependent degradation of the MFalpha mating pheromone and its role in accelerating the time to successful mating using a so-called transcriptonal futile cycle. Another key signaling gene identified during the report period was a novel Specificity protein 1 (SP1) like gene that was found to regulate cell wall integrity. Cell wall integrity is critical to virulence and is a target in a number of successful anti-fungal agents including the echanocandin class of antifungals. In these studies, we identified a transcription factor, Sp1 that shows an evolutionary similarity to higher metazoans such as humans, vs. that of the yeast factor. We showed that, while the yeast factor is regulated by calcineurin, the cryptococcal factor was regulated by protein kinase C under starvation conditions as demonstrated by a dependence on this pathway for phosphorylation and nuclear translocation and is required for virulence of the organism. Previous work in our laboratory had identified cryptococcal laccase as having a role in the production of prostaglandin E2. In collaboration with S. Datta at LCID/NIAID/NIH, we found that induction of PGE2 by host and fungal pathways is important in T17 cell development and antifungal response.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2012
Total Cost
$475,508
Indirect Cost
City
State
Country
Zip Code
Mehta, Gautam U; Panackal, Anil A; Murayi, Roger et al. (2018) Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. J Neurol Neurosurg Psychiatry 89:219-220
Elsegeiny, Waleed; Marr, Kieren A; Williamson, Peter R (2018) Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy. Front Immunol 9:651
Opintan, Japheth A; Awadzi, Benedict K; Biney, Isaac J K et al. (2017) High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana. Trans R Soc Trop Med Hyg 111:464-471
Neal, Lori M; Xing, Enze; Xu, Jintao et al. (2017) CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. MBio 8:
Kwon-Chung, Kyung J; Bennett, John E; Wickes, Brian L et al. (2017) The Case for Adopting the ""Species Complex"" Nomenclature for the Etiologic Agents of Cryptococcosis. mSphere 2:
Sun, Wei; He, Shihua; Martínez-Romero, Carles et al. (2017) Synergistic drug combination effectively blocks Ebola virus infection. Antiviral Res 137:165-172
Park, Yoon-Dong; Sun, Wei; Salas, Antonio et al. (2016) Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening. MBio 7:
Williamson, Peter R (2016) Role of laccase in the virulence of Talaromyces marneffei: A common link between AIDS-related fungal pathogens? Virulence 7:627-9
Panackal, Anil A; Williamson, Kim C; van de Beek, Diederik et al. (2016) Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections. MBio 7:e01906-15
Hu, Guowu; McQuiston, Travis; Bernard, Amélie et al. (2016) Tor-dependent post-transcriptional regulation of autophagy: Implications for cancer therapeutics. Mol Cell Oncol 3:e1078923

Showing the most recent 10 out of 39 publications